BIOMAT Database Logo BIOMAT Database Logo

[Clinical trials of alendronate in Japan]. 2001

M Shiraki
Research Institute and Practice for Involutional Diseases.

Alendronate is the first powerful bisphosphonate which will be available in Japan in near future. Its potencies regarding to the inhibition effect of bone resorption and to increase in bone mineral density were remarkable judging from the data in phase II and III clinical trials. Thus, alendronate is expected to have a potency to inhibit bone fracture occurrence in Japanese osteoporotics.

UI MeSH Term Description Entries

Related Publications

M Shiraki
[Clinical trials of alendronate].
February 2003, Nihon rinsho. Japanese journal of clinical medicine,
M Shiraki
[Clinical trials of alendronate overseas].
January 2001, Clinical calcium,
M Shiraki
Clinical trials in Japan.
January 1995, Nature medicine,
M Shiraki
Clinical pharmacology and clinical trials in Japan.
August 1996, Journal of molecular medicine (Berlin, Germany),
M Shiraki
Clinical trials with interferon in Japan.
January 1981, Texas reports on biology and medicine,
M Shiraki
[Multi regional clinical trials in Japan].
January 2012, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
M Shiraki
[Performing clinical trials efficiently in Japan--independent clinical trials and GCP].
June 2007, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society,
M Shiraki
Multicenter clinical trials of cefoperazone in Japan.
January 1984, Clinical therapeutics,
M Shiraki
Alendronate in the treatment of osteoporosis: a review of the clinical trials.
January 2000, Journal of women's health & gender-based medicine,
M Shiraki
Prevention of misconduct in clinical trials in Japan.
September 2014, Lancet (London, England),
Copied contents to your clipboard!